Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma

12 Apr 2011

Abstract excerpt

Application of advances in genomic and proteomic technologies has provided molecular insights into distinct types of aggressive B- and T-cell non-Hodgkin's lymphomas (NHLs). This has led to the validation of novel biomarkers of classification, risk-stratification, and druggable targets. The promise of novel treatments from genomic research has been slow to materialize because of the lack of a therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Lymphoma Diagnosis and Treatment
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21483007
DOI: 10.1200/jco.2010.32.7171

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Therapeutics for Aggressive Non-Hodgkin's LymphomaPMID 21483007Read ↗

New targeted therapies for malignant lymphoma based on molecular heterogeneity.Semantic proximity Read ↗

The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.Semantic proximity Read ↗

Precision therapy for lymphoma--current state and future directions.Semantic proximity Read ↗

Diffuse large B cell lymphoma: molecular targeted therapy.Semantic proximity Read ↗

Novel treatment for mantle cell lymphoma - impact of BTK inhibitors and beyond.Semantic proximity Read ↗

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.Semantic proximity Read ↗

Development of molecular intervention strategies for B-cell lymphoma.Semantic proximity Read ↗

Malignant lymphoma: pathophysiology and current therapy.Semantic proximity Read ↗

Genetic and molecular targets in lymphoma: implications for prognosis and treatment.Semantic proximity Read ↗

Histone Modifications and Their Targeting in Lymphoid MalignanciesSemantic proximity Read ↗

New Insights into Lymphoma PathogenesisSemantic proximity Read ↗

Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.